The best candidates for lung volume reduction surgery are patients with an FEV1 20 to 40% of predicted, a DLCO > 20% of predicted, significantly impaired exercise capacity, heterogeneous pulmonary disease on CT with an upper-lobe predominance, PaCO2 < 50 mm Hg, and absence of severe pulmonary hypertension and coronary artery disease.